Zürich BioGenix
BPC-157 · 5mg
BPC-157 · 5mg
Couldn't load pickup availability
✓ HPLC Purity >99% ✓ COA on Every Batch ✓ Cold Chain Maintained ✓ EU Compliant
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protective protein found in gastric juice. It demonstrates cytoprotective and organoprotective effects across multiple tissue types. Research has documented its role in upregulation of growth hormone receptor expression, VEGF-mediated angiogenesis, and nitric oxide pathway modulation. Study areas include tendon and ligament repair, gut-barrier restoration, neurological protection, and musculoskeletal healing models.
Synthesised and lyophilised in Zürich to >99% HPLC purity. Lot-traceable with full COA available upon request.
Technical Specifications
| Chemical Name | Pentadecapeptide BPC-157 |
| CAS Number | 137525-51-0 |
| Molecular Formula | C₆₂H₉₈N₁₆O₂₂ |
| Molecular Weight | 1419.56 g/mol |
| Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Purity | >99% (HPLC-UV) |
| Form | Lyophilised Powder |
| Storage | –20°C, protect from light and moisture |
| Reconstitution | Bacteriostatic water or sterile saline |
Research & Literature
BPC-157 has been studied across numerous animal models since the 1990s. Key areas of investigation include: gastrointestinal mucosal protection (Sikiric et al.), tendon-to-bone healing acceleration, peripheral nerve regeneration, and modulation of dopaminergic/serotonergic systems. The peptide demonstrates a stable resistance to proteolysis in gastric juice, distinguishing it from other gut-derived peptides.
For research purposes only. Not for human consumption. Supplied in accordance with EU Regulation (EC) No 1907/2006 (REACH) for research and analytical use.
Share
